Azargen Biotechnologies

Azargen Biotechnologies

Azargen Biotechnologies

A biotechnology company utilising advanced genetic engineering and synthetic biology techniques to express biopharmaceutical compounds of high value.
Raised
$3.1M
Follow us
Alexa global traffic share
Latest funding
$3,100,000
Venture capital (Series B) - 2016
Team Size
1–10
Employees
$3,100,000 Venture capital (Series B)
Venture Capital for Africa

AzarGen Biotechnologies closes $3.1 million in Series B funding